ArticleCancers2026
Improving Diagnostic Sensitivity in Imbalanced Oral Cancer Image Classification: A Comparative Study of CNN and Transformer Architectures.
Article in Cancers, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundClass imbalance remains a major limitation in artificial intelligence based oral cancer diagnosis, particularly in small clinical image datasets where malignant lesions are underrepresented.
methodsUsing a dataset of 3000 mobile-acquired oral cavity images categorized into four diagnostic classes (healthy, benign, oral potentially malignant disorders, and oral cancer), we systematically evaluated the impact of imbalance mitigation strategies on diagnostic performance. Three backbone architectures, EfficientNet, Vision Transformer, and Swin Transformer, were trained under four conditions: raw imbalanced training, random under-sampling, random over-sampling, and medical-safe data augmentation. Performance was evaluated using stratified five-fold cross-validation, and all reported metrics correspond to the mean performance across the validation folds.
resultsIn multiclass evaluation, augmentation yielded the strongest overall performance, with EfficientNet achieving the highest macro-F1 score (0.669 ± 0.024) and area under curve (0.881 ± 0.015). Under clinically oriented binary malignant-risk evaluation (high-risk vs. low-risk lesions), sensitivity reached 0.817 ± 0.030 with EfficientNet, while data augmentation maintained competitive malignant-risk detection across the evaluated architectures. In contrast, random undersampling consistently yielded lower descriptive performance across architectures.
conclusionsThese findings indicate that augmentation-based imbalance mitigation is associated with improved multiclass and oral cancer specific performance while maintaining competitive overall discrimination. The results provide practical guidance for developing clinically robust artificial intelligence systems for early oral cancer detection in imbalanced real-world datasets.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.